insights_auto
Why is ZTS down 2.10%?
Dive Deeperchevron_right
ZTS:NYSE
Zoetis Inc
$79.11
arrow_downward
-2.10%(-1.70) 1D
$78.16
arrow_downward
-1.20% (-0.95)bedtimeAfter hours
Closed: Nov 20, 4:00:04 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ZTS...
Open
$81.73
High
$83.08
Low
$78.80
Mkt. cap
32.14B
Avg. vol.
4.41M
Volume
6.10M
Dividend
2.68%
Quarterly dividend
$0.53
Ex-dividend date
Oct 30, 2026
P/E ratio
13.44
52-wk high
$132.49
52-wk low
$68.77
EPS
$5.89
Beta
0.67
Shares outstanding
406.32M
No. of employees
14K
Open
$81.73
High
$83.08
Low
$78.80
Mkt. cap
32.14B
Avg. vol.
4.41M
Volume
6.10M
Dividend
2.68%
Quarterly dividend
$0.53
Ex-dividend date
Oct 30, 2026
P/E ratio
13.44
52-wk high
$132.49
52-wk low
$68.77
EPS
$5.89
Beta
0.67
Shares outstanding
406.32M
No. of employees
14K
News stories
From web sources and news partners
Yahoo Finance
·
7 hours ago
Zoetis Inc. (ZTS) Stock Forecasts
kalkine.ca
·
15 hours ago
Zoetis (NYSE:ZTS) in Focus: Unusual Volume and Third-Quarter Results
Benzinga
·
16 hours ago
Michael Burry Halves SMH, Nvidia Puts but Keeps Nasdaq 100 Bet
Trefis
·
1 day ago
Why Did Zoetis Stock Move?
Profile
Zoetis Inc., headquartered in Parsippany, New Jersey, is the largest producer of medicine and vaccinations for pets and livestock worldwide. The company's products include antiparasitics, vaccines, products that relieve itch, anti-infectives, products that alleviate pain, animal health diagnostics, as well as hormones, cardiopulmonary, topical and oral hygiene therapeutics, central nervous system drugs, diuretics, antiemetic, euthanasia, and hepato-digestive products. The company has operations in over 50 countries.
In 2025, 70% of the company's revenue came from products for pets and 29% of the company's revenues came from products for livestock. In 2025, 54% of the company's revenue came from customers in the United States. Of this revenue, 79% came from products for dogs and cats, 13% came from products for cattle, and 4% came from products for horses. In 2025, 46% of the company's revenue came from international customers. Of this revenue, 53% came from products for dogs and cats, 19% came from products for cattle, 9% came from products for swine, 7% came from products for poultry, and 3% came from products for horses. Wikipedia
About Zoetis Inc
CEOKristin C. Peck
Employees14.5K
Founded1952
HeadquartersParsippany-Troy Hills, New Jersey, United States
SectorHealth Care
IndustryPharmaceutical industry
Websitezoetis.com